STEMLIFE BHD
(Bursa: 0137)

StemLife is the first stem cell banking and therapeutics company in Malaysia. Established in 2001 with blessings from the Malaysian Government, StemLife was awarded the prestigious MSC status in 2002, BioNexus Status in 2007 and on 17 October 2006 the company went for listing on the MESDAQ. As of 2008, StemLife is a fully licensed cord blood banking facility under the Private Healthcare Services & Facilities Act (PHFS Act), 1998, under the Ministry of Health Malaysia.StemLife is proud to be the first cord blood banking company in Malaysia to provide umbilical cord blood-derived stem cells.

0.565 S

- (-%)
价格区间 0.565 - 0.565   (-%)
开盘 0.565
昨收 0.565
-
买盘 ('00) -
-
卖盘 ('00) -
成交量 ('00) -
成交额 -
注释 S
数据延迟。最后一次更新21 Feb 2017 06:05.
数据提供商
查看所有活动

Please login to view stock data and analysis